Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide and the most common
arrhythmia leading to hospitalization. Due to a substantial increase in incidence and …

Aims Major practice changes require both clinical and economic rationale, especially where
a novel device replaces an established pharmaceutical therapy. Recent studies have …

Aims This study aims to estimate the cost-effectiveness of percutaneous left atrial
appendage occlusion (LAAO) compared to standard stroke prevention care for patients with …

Atrial fibrillation (AF) is the most common arrhythmia affecting elderly patients. Management
and treatment of AF in this rapidly growing population of older patients involve a …

Background—Safety data on percutaneous left atrial appendage closure arises from centers
with considerable expertise in the procedure or from clinical trial, which might not be …

2362 Circulation June 10, 2014 increasing prevalence of these risk factors is fueling the
underlying atrial substrates that predispose to the development of AF. Public health …

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is characterized
by unco-ordinated atrial activation with consequent loss of atrial mechanical function. In …

Objectives To systematically review and synthesize the literature on the costs of atrial
fibrillation (AF) with attention to study design and costing methods, geography, and …

Background—Percutaneous left atrial appendage (LAA) occlusion and novel
pharmacological therapies are now available to manage stroke risk in patients with …

Background: The comparative real-world outcomes of older patients with atrial fibrillation
(AF) treated with anticoagulation compared with left atrial appendage occlusion (LAAO) may …